-
Mashup Score: 0Edoxaban an ‘Appropriate Alternative’ to Standard-of-Care Anticoagulants for Thromboembolism Prevention in Children: Phase 3 Data - 1 year(s) ago
The direct oral anticoagulant (DOAC) edoxaban is a potential alternative mode of thromboprophylaxis in children with cardiac disease showing low rates of clinically relevant bleeding (CRB) and thrombo
Categories: Cardiology News and Journals, Latest HeadlinesTweet
-
Mashup Score: 5Highlow study - American College of Cardiology - 1 year(s) ago
Anthony A. Bavry, MD, MPH, FACC
Source: American College of CardiologyCategories: Cardiology News and Journals, Latest HeadlinesTweet
-
Mashup Score: 1
Preventing limb loss through vascular interventions and venous therapies were the focus of the BEST-CLI, BEST-CLI QOL, PREVENT-HD and the IMPROVE trials presented Nov. 7 during AHA 2022 in Chicago. In BEST-CLI, researchers compared the clinical, safety, quality of life and cost outcomes in more than 1,800 patients with chronic limb-threatening ischemia (CLTI) and infrainguinal peripheral artery…
Source: American College of CardiologyCategories: Cardiology News and Journals, Latest HeadlinesTweet
-
Mashup Score: 4
We are grateful to these distinguished faculty who contributed to this collection: Faculty Chairs: Geoffrey Barnes, MD, MSc, FACC Stanislav Henkin, MD, MPH, FACC Faculty: Anastasia Armbruster, PharmD, FACC Craig J. Beavers, PharmD, FACC Teresa L. Carman, MD Robert D. McBane II, MD Jordan Schaefer, MD
Source: learn.acc.orgCategories: Cardiology News and Journals, Latest HeadlinesTweet
-
Mashup Score: 4Risk Factors for Acute Incident VTE in Ambulatory COVID-19 Patients - American College of Cardiology - 2 year(s) ago
Geoffrey D. Barnes, MD, MSc, FACC
Source: American College of CardiologyCategories: Cardiology News and Journals, Latest HeadlinesTweet
-
Mashup Score: 1Nuances of Direct Oral Anticoagulants: Panel Discussion - 2 year(s) ago
Description This activity is part of the Practical Management of VTE: Simplifying Anticoagulation Strategies grant.Accreditation Statement In accordance with ACCME policy, prior to participating in this activity, you must review the information on this page. Joint Accreditation In support of improving…
Source: learn.acc.orgCategories: Cardiology News and Journals, Latest HeadlinesTweet
-
Mashup Score: 1
Recent developments of interest in cardiovascular medicine
Source: www.medpagetoday.comCategories: Cardiology News and Journals, Latest HeadlinesTweet
-
Mashup Score: 7Peripheral Matters | Transforming Acute PE Care: Standardizing Management to Improve Outcomes - American College of Cardiology - 2 year(s) ago
Venous thromboembolism (VTE), including pulmonary embolism (PE) and deep vein thrombosis (DVT), is the third most frequent cause of cardiovascular death globally. Within the U.S. alone there are 900,000 cases of VTE annually and an estimated 200,000-250,000 related hospitalizations.1 The growth in device-based interventions coupled with the lack of a standardized treatment strategy has led to an…
Source: American College of CardiologyCategories: Cardiology News and Journals, Latest HeadlinesTweet
-
Mashup Score: 3Xyleme Syndicate Portal - 2 year(s) ago
{{‘document.preview.not.available’ | i18n}} {{‘document.preview.open.in.new.window’ | i18n}} {{‘document.preview.click.in.new.window’ | i18n}}
Source: acc.bravais.comCategories: Cardiology News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0Tranexamic Acid For the Prevention of Perioperative Bleeding - American College of Cardiology - 2 year(s) ago
Perioperative bleeding is a key complication associated with increased morbidity and mortality.1 Due to an aging population worldwide, the bleeding and thrombotic risk of patients undergoing noncardiac surgery is increasing.2 Tranexamic acid is an antifibrinolytic drug3 that has been shown in large clinical trials to decrease the incidence and severity of bleeding during cesarean section and…
Source: American College of CardiologyCategories: Cardiology News and Journals, Latest HeadlinesTweet
The #NOAC edoxaban could be an alternative mode of thromboprophylaxis in children w/ cardiac disease w/ low rates of CRB and thromboembolism, according to the results of the ENNOBLE-ATE trial in #JACC. Find out more in @CRT_meeting: https://t.co/ILgWQ2aPJM #cvVTE #NOAC